On 18-19 January 2024, the AI-PROGNOSIS consortium met in Leuven, Belgium, for the second plenary meeting.

Over two highly productive days, partners reviewed the status of work packages and planned the next steps towards advancing Parkinson’s disease diagnosis and care through novel predictive models combined with digital biomarkers from everyday devices.

The agenda also included four workshops involving clinicians, researchers and developers:

·      Overview and introduction to the AI-PROGNOSIS tools (mAI-Health, mAI-Care, mAI-Insights) and co-creation planning;

·      Discussion on retrospective data harmonisation strategy and role assignment;

·      Exploring data analysis common practices under the Trustworthy AI development and evaluation framework;

·      Discussion on the dBM-DEV study, focusing on app features, study deployment and participant onboarding.

By integrating cutting-edge technologies and embracing a multidisciplinary approach, the consortium aims to revolutionise the landscape of Parkinson's disease diagnosis and care, ultimately improving the lives of those affected by this condition.